tiprankstipranks
Nath Bio-Genes (India) Ltd. (IN:NATHBIOGEN)
:NATHBIOGEN
India Market
NATHBIOGEN
Nath Bio-Genes (India) Ltd.
RESEARCH TOOLSreports

Nath Bio-Genes (India) Ltd. (NATHBIOGEN) Ratios

3 Followers

Nath Bio-Genes (India) Ltd. Ratios

IN:NATHBIOGEN's free cash flow for Q2 2026 was ₹0.35. For the 2026 fiscal year, IN:NATHBIOGEN's free cash flow was decreased by ₹ and operating cash flow was ₹0.21. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 2.23 1.89 2.18 2.41 2.41
Quick Ratio
 1.26 0.96 1.30 1.45 1.27
Cash Ratio
 <0.01 0.24 0.29 0.18 0.02
Solvency Ratio
 0.15 0.11 0.16 0.17 -0.32
Operating Cash Flow Ratio
 -0.34 0.05 0.28 0.18 0.09
Short-Term Operating Cash Flow Coverage
 -0.77 0.16 0.71 0.37 0.18
Net Current Asset Value
₹ 3.72B₹ 3.08B₹ 3.01B₹ 3.01B₹ 2.68B
Leverage Ratios
Debt-to-Assets Ratio
 0.15 0.12 0.13 0.13 0.13
Debt-to-Equity Ratio
 0.23 0.19 0.18 0.18 0.17
Debt-to-Capital Ratio
 0.19 0.16 0.15 0.16 0.15
Long-Term Debt-to-Capital Ratio
 0.02 0.02 <0.01 <0.01 <0.01
Financial Leverage Ratio
 1.49 1.59 1.44 1.38 1.37
Debt Service Coverage Ratio
 0.39 0.40 0.45 0.42 -0.52
Interest Coverage Ratio
 3.46 4.39 5.41 16.97 12.93
Debt to Market Cap
 0.53 0.41 0.32 0.39 0.23
Interest Debt Per Share
 88.19 68.41 62.70 60.74 54.52
Net Debt to EBITDA
 2.47 0.67 0.61 1.37 -1.79
Profitability Margins
Gross Profit Margin
48.97%62.85%41.66%55.33%55.46%
EBIT Margin
13.05%12.60%20.28%15.18%-18.96%
EBITDA Margin
14.01%13.65%21.67%16.23%-17.86%
Operating Profit Margin
9.90%12.60%19.27%57.52%49.43%
Pretax Profit Margin
10.19%10.97%16.79%12.05%-22.77%
Net Profit Margin
10.14%10.58%16.01%11.62%-24.19%
Continuous Operations Profit Margin
9.68%10.58%16.01%11.62%-24.21%
Net Income Per EBT
99.57%96.39%95.32%96.40%106.23%
EBT Per EBIT
102.91%87.09%87.13%20.96%-46.07%
Return on Assets (ROA)
4.46%3.76%4.50%4.42%-9.08%
Return on Equity (ROE)
6.93%5.99%6.50%6.11%-12.42%
Return on Capital Employed (ROCE)
6.32%6.96%7.72%30.07%25.13%
Return on Invested Capital (ROIC)
4.94%5.67%6.29%24.64%21.58%
Return on Tangible Assets
4.48%3.79%4.55%4.47%-9.23%
Earnings Yield
15.55%12.88%11.46%13.04%-16.61%
Efficiency Ratios
Receivables Turnover
 1.95 4.10 2.62 3.10 3.25
Payables Turnover
 3.28 1.71 3.34 4.85 2.90
Inventory Turnover
 0.74 0.40 0.63 0.65 0.56
Fixed Asset Turnover
 1.83 1.50 0.88 1.29 1.20
Asset Turnover
 0.44 0.36 0.28 0.38 0.38
Working Capital Turnover Ratio
 2.29 1.15 0.81 1.04 0.87
Cash Conversion Cycle
 570.68 785.09 611.74 606.35 635.03
Days of Sales Outstanding
 187.53 88.92 139.07 117.91 112.24
Days of Inventory Outstanding
 494.44 910.20 582.11 563.66 648.75
Days of Payables Outstanding
 111.30 214.03 109.43 75.22 125.96
Operating Cycle
 681.98 999.13 721.17 681.57 760.99
Cash Flow Ratios
Operating Cash Flow Per Share
 -57.19 9.04 39.25 20.19 8.97
Free Cash Flow Per Share
 -57.77 4.97 25.16 18.85 -2.09
CapEx Per Share
 0.58 4.07 14.09 1.34 11.06
Free Cash Flow to Operating Cash Flow
 1.01 0.55 0.64 0.93 -0.23
Dividend Paid and CapEx Coverage Ratio
 -22.16 1.50 2.44 6.04 0.69
Capital Expenditure Coverage Ratio
 -98.40 2.22 2.79 15.05 0.81
Operating Cash Flow Coverage Ratio
 -0.70 0.14 0.68 0.36 0.18
Operating Cash Flow to Sales Ratio
 -0.24 0.05 0.30 0.13 0.06
Free Cash Flow Yield
-37.77%3.22%13.83%13.34%-0.98%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 6.43 7.76 8.73 7.67 -6.02
Price-to-Sales (P/S) Ratio
 0.65 0.82 1.40 0.89 1.46
Price-to-Book (P/B) Ratio
 0.43 0.47 0.57 0.47 0.75
Price-to-Free Cash Flow (P/FCF) Ratio
 -2.65 31.02 7.23 7.49 -102.12
Price-to-Operating Cash Flow Ratio
 -2.67 17.05 4.63 7.00 23.79
Price-to-Earnings Growth (PEG) Ratio
 -2.85 -3.00 0.66 -0.05 0.03
Price-to-Fair Value
 0.43 0.47 0.57 0.47 0.75
Enterprise Value Multiple
 7.12 6.69 7.06 6.87 -9.94
Enterprise Value
 4.45B 3.33B 3.79B 3.36B 4.94B
EV to EBITDA
 7.12 6.69 7.06 6.87 -9.94
EV to Sales
 1.00 0.91 1.53 1.11 1.78
EV to Free Cash Flow
 -4.05 34.50 7.92 9.37 -124.48
EV to Operating Cash Flow
 -4.09 18.96 5.08 8.75 28.99
Tangible Book Value Per Share
 354.36 327.81 316.31 296.12 278.86
Shareholders’ Equity Per Share
 357.74 331.51 320.94 301.61 285.19
Tax and Other Ratios
Effective Tax Rate
 0.06 0.05 0.05 0.03 -0.06
Revenue Per Share
 234.41 187.73 130.25 158.54 146.47
Net Income Per Share
 23.78 19.86 20.85 18.42 -35.43
Tax Burden
 1.00 0.96 0.95 0.96 1.06
Interest Burden
 0.78 0.87 0.83 0.79 1.20
Research & Development to Revenue
 0.00 0.00 0.05 0.03 0.03
SG&A to Revenue
 0.29 0.41 0.03 0.02 0.02
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 -1.33 0.46 1.79 1.06 -0.27
Currency in INR